Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 1 INDUSTRY
2.1 Summary about Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry
2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Trends
2.2.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Production & Consumption Trends
2.2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Demand Structure Trends
2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 CMX-020
4.2.2 CA-016
4.2.3 DD-04107
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Ophthalmology
4.3.2 Immunology
4.3.3 Muscle Spasm
4.3.4 Pruritus
4.3.5 Abdominal Pain
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 CMX-020
5.2.2 CA-016
5.2.3 DD-04107
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Ophthalmology
5.3.2 Immunology
5.3.3 Muscle Spasm
5.3.4 Pruritus
5.3.5 Abdominal Pain
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 CMX-020
6.2.2 CA-016
6.2.3 DD-04107
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Ophthalmology
6.3.2 Immunology
6.3.3 Muscle Spasm
6.3.4 Pruritus
6.3.5 Abdominal Pain
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 CMX-020
7.2.2 CA-016
7.2.3 DD-04107
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Ophthalmology
7.3.2 Immunology
7.3.3 Muscle Spasm
7.3.4 Pruritus
7.3.5 Abdominal Pain
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 CMX-020
8.2.2 CA-016
8.2.3 DD-04107
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Ophthalmology
8.3.2 Immunology
8.3.3 Muscle Spasm
8.3.4 Pruritus
8.3.5 Abdominal Pain
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 CMX-020
9.2.2 CA-016
9.2.3 DD-04107
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Ophthalmology
9.3.2 Immunology
9.3.3 Muscle Spasm
9.3.4 Pruritus
9.3.5 Abdominal Pain
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Amgen Inc
10.1.2 Amorepacific Corp
10.1.3 BCN Peptides SA
10.1.4 Centrexion Therapeutics Corp
10.1.5 Daewoong Pharmaceutical Co Ltd
10.1.6 DoNatur GmbH
10.1.7 Flex Pharma Inc
10.1.8 Grunenthal GmbH
10.1.9 Kyowa Hakko Kirin Co Ltd
10.1.10 Medifron DBT Co Ltd
10.1.11 Neurim Pharmaceuticals Ltd
10.1.12 Pila Pharma AB
10.1.13 Sylentis SAU
10.1.14 Toray Industries Inc
10.1.15 Vitality Biopharma Inc
10.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Date of Major Players (2017-2020e)
10.2.1 Amgen Inc
10.2.2 Amorepacific Corp
10.2.3 BCN Peptides SA
10.2.4 Centrexion Therapeutics Corp
10.2.5 Daewoong Pharmaceutical Co Ltd
10.2.6 DoNatur GmbH
10.2.7 Flex Pharma Inc
10.2.8 Grunenthal GmbH
10.2.9 Kyowa Hakko Kirin Co Ltd
10.2.10 Medifron DBT Co Ltd
10.2.11 Neurim Pharmaceuticals Ltd
10.2.12 Pila Pharma AB
10.2.13 Sylentis SAU
10.2.14 Toray Industries Inc
10.2.15 Vitality Biopharma Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Type Overview
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Type Market Share List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Type of Major Players
Table Brief Introduction of Amgen Inc
Table Brief Introduction of Amorepacific Corp
Table Brief Introduction of BCN Peptides SA
Table Brief Introduction of Centrexion Therapeutics Corp
Table Brief Introduction of Daewoong Pharmaceutical Co Ltd
Table Brief Introduction of DoNatur GmbH
Table Brief Introduction of Flex Pharma Inc
Table Brief Introduction of Grunenthal GmbH
Table Brief Introduction of Kyowa Hakko Kirin Co Ltd
Table Brief Introduction of Medifron DBT Co Ltd
Table Brief Introduction of Neurim Pharmaceuticals Ltd
Table Brief Introduction of Pila Pharma AB
Table Brief Introduction of Sylentis SAU
Table Brief Introduction of Toray Industries Inc
Table Brief Introduction of Vitality Biopharma Inc
Table Products & Services of Amgen Inc
Table Products & Services of Amorepacific Corp
Table Products & Services of BCN Peptides SA
Table Products & Services of Centrexion Therapeutics Corp
Table Products & Services of Daewoong Pharmaceutical Co Ltd
Table Products & Services of DoNatur GmbH
Table Products & Services of Flex Pharma Inc
Table Products & Services of Grunenthal GmbH
Table Products & Services of Kyowa Hakko Kirin Co Ltd
Table Products & Services of Medifron DBT Co Ltd
Table Products & Services of Neurim Pharmaceuticals Ltd
Table Products & Services of Pila Pharma AB
Table Products & Services of Sylentis SAU
Table Products & Services of Toray Industries Inc
Table Products & Services of Vitality Biopharma Inc
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast (Million USD) by Region 2021f-2026f
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast (Million USD) Share by Demand 2021f-2026f